Avails Medical, based in Menlo Park, CA, is a pioneering company aiming to revolutionize antibiotic susceptibility testing (AST) in the Sepsis Bacteremia diagnostics market. With their innovative eQUANT system, they offer an accelerated workflow that can save up to 24 hours in the current AST process, crucial for timely treatment of sepsis, a life-threatening condition that costs the US healthcare system $24 billion annually.
By replacing four manual steps with one automated step, Avails Medical's eQUANT system generates a 0.5 McFarland directly from a PBC in as fast as 40 minutes, making it compatible with any established AST systems. With sepsis mortality rates far surpassing those of prostate cancer, breast cancer, and AIDS combined, Avails Medical's mission is to become the global leader in accelerated antibiotic susceptibility testing, addressing a significant problem in a large market.
Generated from the website